Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 178,600 | 88,000 | 96,100 | 72,600 | 48,900 |
| Receivables | 118,500 | 125,900 | 124,900 | 127,700 | 119,400 |
| Inventories | 131,500 | 135,500 | 131,300 | 126,100 | 127,700 |
| Income taxes - deferred | 27,600 | 13,900 | 15,000 | 17,500 | 21,100 |
| Other current assets | 0 | 0 | 0 | 0 | 8,200 |
| TOTAL | $514,200 | $430,400 | $437,100 | $400,600 | $367,500 |
| Non-Current Assets | |||||
| PPE Net | 201,900 | 192,100 | 193,000 | 195,400 | 201,700 |
| Investments And Advances | 10,700 | 14,500 | 14,100 | 17,300 | 20,600 |
| Intangibles | 475,400 | 479,500 | 483,600 | 480,800 | 490,300 |
| Other Non-Current Assets | 26,900 | 28,500 | 23,000 | 29,000 | 32,600 |
| TOTAL | $714,900 | $714,600 | $713,700 | $722,500 | $745,200 |
| Total Assets | $1,229,100 | $1,145,000 | $1,150,800 | $1,123,100 | $1,112,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 60,700 | 204,600 | 190,400 | 176,400 | 195,400 |
| Accrued Expenses | 108,300 | N/A | N/A | N/A | N/A |
| TOTAL | $194,200 | $204,600 | $190,400 | $176,400 | $195,400 |
| Non-Current Liabilities | |||||
| Long Term Debt | 316,100 | 251,500 | 269,600 | 275,800 | 267,100 |
| Other Non-Current Liabilities | 28,800 | 29,700 | 29,100 | 22,800 | 22,100 |
| TOTAL | $344,900 | $281,200 | $298,700 | $298,600 | $289,200 |
| Total Liabilities | $539,100 | $485,800 | $489,100 | $475,000 | $484,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 710,879 | 713,565 | 717,612 | 714,421 | 714,998 |
| Common Shares | 65,600 | 65,400 | 65,000 | 64,600 | 64,200 |
| Retained earnings | 303,400 | 264,700 | 269,100 | 255,300 | 224,100 |
| Other shareholders' equity | -21,700 | -22,900 | -33,900 | -25,800 | -20,800 |
| TOTAL | $690,000 | $659,200 | $661,700 | $648,100 | $628,100 |
| Total Liabilities And Equity | $1,229,100 | $1,145,000 | $1,150,800 | $1,123,100 | $1,112,700 |